265 related articles for article (PubMed ID: 10398124)
21. Cyclin D3 expression in primary Ta/T1 bladder cancer.
Lopez-Beltran A; Requena MJ; Luque RJ; Alvarez-Kindelan J; Quintero A; Blanca AM; Rodriguez ME; Siendones E; Montironi R
J Pathol; 2006 May; 209(1):106-13. PubMed ID: 16482499
[TBL] [Abstract][Full Text] [Related]
22. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
[TBL] [Abstract][Full Text] [Related]
24. Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis.
Bartkova J; Thullberg M; Rajpert-De Meyts E; Skakkebaek NE; Bartek J
Oncogene; 2000 Aug; 19(36):4146-50. PubMed ID: 10962575
[TBL] [Abstract][Full Text] [Related]
25. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
[TBL] [Abstract][Full Text] [Related]
27. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
28. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
Glassford J; Rabin N; Lam EW; Yong KL
Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
[TBL] [Abstract][Full Text] [Related]
29. [Changes in cyclin expression during proliferation and differentiation of CD34(+) cells derived from fetal liver induced by thrombopoietin].
Ma DC; Jin BQ; Sun YH; Chang KZ; Dai B; Chu JJ; Liu YG
Sheng Li Xue Bao; 2001 Aug; 53(4):296-302. PubMed ID: 11930209
[TBL] [Abstract][Full Text] [Related]
30. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia.
Meyerson HJ; MacLennan G; Husel W; Cocco A; Tse W; Lazarus HM; Kaplan D
Am J Clin Pathol; 2006 Feb; 125(2):241-50. PubMed ID: 16393687
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer.
Russell A; Thompson MA; Hendley J; Trute L; Armes J; Germain D
Oncogene; 1999 Mar; 18(11):1983-91. PubMed ID: 10208420
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein.
Bartkova J; Lukas J; Strauss M; Bartek J
J Pathol; 1994 Mar; 172(3):237-45. PubMed ID: 8195927
[TBL] [Abstract][Full Text] [Related]
33. The effect of cyclin D expression on cell proliferation in human gliomas.
Zhang X; Zhao M; Huang AY; Fei Z; Zhang W; Wang XL
J Clin Neurosci; 2005 Feb; 12(2):166-8. PubMed ID: 15749420
[TBL] [Abstract][Full Text] [Related]
34. Expression of cyclin genes in human gastric cancer and in first degree relatives.
Yu J; Miehlke S; Ebert MP; Szokodi D; Wehvnignh B; Malfertheiner P; Ehninger G; Bayerdoerffer E
Chin Med J (Engl); 2002 May; 115(5):710-5. PubMed ID: 12133540
[TBL] [Abstract][Full Text] [Related]
35. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
36. Deregulation of the RB pathway in human testicular germ cell tumours.
Bartkova J; Lukas C; Sørensen CS; Rajpert-De Meyts E; Skakkebaek NE; Lukas J; Bartek J
J Pathol; 2003 Jun; 200(2):149-56. PubMed ID: 12754735
[TBL] [Abstract][Full Text] [Related]
37. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein.
Bates S; Parry D; Bonetta L; Vousden K; Dickson C; Peters G
Oncogene; 1994 Jun; 9(6):1633-40. PubMed ID: 8183557
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of cyclins A, B1, D3 and E in G1 phase of the cell cycle between the synchronized and asynchronously growing MOLT-4 cells.
Yu C; Hu J; Feng Y; Tao D; Wu J; Qin J; Liu S; Zhang M; Wang G; Li X; Zhao J; Ding H; Reed E; Li QQ; Gong J
Int J Mol Med; 2005 Oct; 16(4):645-51. PubMed ID: 16142399
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
Weroha SJ; Li SA; Tawfik O; Li JJ
Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245
[TBL] [Abstract][Full Text] [Related]
40. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes.
Kiess M; Gill RM; Hamel PA
Oncogene; 1995 Jan; 10(1):159-66. PubMed ID: 7824268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
